Dec 14, 2021 The CJEU’s Decision in Boehringer Ingelheim v Tax and Customs Appeals Directorate, Hungary By Maura Dineen Tudor Nedelea Patrick O'Donovan On 6 October 2021 the Court of Justice of the European Union (the “CJEU”) released its judgment in the case of Boehringer Ingelheim RCV...
Dec 14, 2021 Drug price controls make industry critics feel better, but won’t make people feel healthier By Kirsten Axelsen Please note: Article was first published in The American Enterprise Institute for Public Policy Research In Build Back Better, price...
Dec 13, 2021 Do medical devices have systematic bias? By Kate Black Anna Ward An investigation has been launched by the UK’s Department of Health and Social Care (“DHSC”) with the overall aim of improving healthcare...
Dec 06, 2021 The importance of regional innovation hubs in supporting the UK's Life Sciences Vision By Lyndsey Hudson Following on from my recent comments about the UK being a viable location to be a life sciences startup - with the right governmental...
Dec 03, 2021 Portugal establishes new rules on the revision of the prices for medicinal products By Mariana Ricardo Ordinance no. 280/2021, dated 3 December (entering into force on December 4, 2021) creates an exceptional criterion to be used in the...
Nov 25, 2021 Luxembourg refines its draft bill on recreational cannabis By Olivier Reisch David Alexandre Back in 2018, as part of the coalition agreement between political parties (Accord de coalition 2018-2023), the Luxembourg government...
Nov 25, 2021 Advertising of medical devices: Italian Ministry of Health confirms national pre-authorization requirement despite MDR By Carlotta Busani Marco de Morpurgo With Circular 0081386 dated 12 November 2021, the Italian Ministry of Health confirmed that the national pre-authorization requirements...
Nov 23, 2021 Is the UK the right home for life sciences startups? By Lyndsey Hudson I saw this recent article highlighting the need for the UK to create a much more supportive and sustainable environment for life sciences...
Nov 17, 2021 Assessing the value of medicine for diverse patients: Implications of a QALY approach for health disparities By Kirsten Axelsen Momentum and debate about the application of cost-effectiveness analysis to determine the value and prices of prescription drugs in the...
Nov 11, 2021 The unhealthy healthcare system – a view on the treatment of medical waste By Inês Santana Metello Mariana Ricardo Countries and industries have been progressively setting ‘net zero’ targets, adapting legislation and activities to move towards a...
Nov 11, 2021 Social media's impact on the life sciences industry (podcast) By Christopher Campbell Jody Rhodes As part of our on-going podcast series - At the intersection of Science and Law, DLA Piper partners Chris Campbell and Jody Rhodes are...
Nov 08, 2021 Poland discusses draft laws to facilitate the cultivation of hemp By Amelia Prawda Andrzej Balicki, Ph.D. On 20 April 2021, the draft bill on hemp ("Draft Bill") was submitted to the Sejm (the lower house of the Polish Parliament). The aim of...
Nov 08, 2021 Telehealth and Australia's mental health care transformation By Matt Rozario Greg Bodulovic Alexandra Moore Australia continues to rapidly integrate telehealth as an accepted and much desired element of health care delivery, in particular within...
Nov 03, 2021 New draft law initiatives to tackle medical waste in Romania By Amalia Musat On 11 October 2021, the Senate of Romania adopted the following initiatives to tackle medical waste in Romania. (i) Draft Law on the...
Oct 17, 2021 Patent term extensions in Australia – What if the patent covers more than one approved product? By Nicholas Tyacke Alexandra de Zwart In its second significant recent decision addressing patent term extensions in Australia, the Federal Court of Australia, in Merck Sharp...
Oct 08, 2021 Key takeaways from the ABPI Clinical Research Report 2021 By Richard Taylor Elinor Cavil The ABPI (Association of British Pharmaceutical Industries, the UK trade association for producers of prescription medicines) launched...